Effect of metabolic dysfunction‐associated steatotic liver disease on BNT162b2 immunogenicity against the severe acute respiratory syndrome coronavirus 2 omicron variant

Documenti analoghi

• Metabolic dysfunction‐associated steatotic liver disease and BNT162b2 immunogenicity against the severe acute respiratory syndrome coronavirus 2 omicron variant: correspondence
  di: H Daungsupawong, et al.
  Pubblicazione: (2024)
• Effects of Successful Versus Delayed/Failed Helicobacter pylori Eradication Therapy on Subsequent Fracture Risk: a Population‐Based Cohort Study
  di: Jing Tong Tan, et al.
  Pubblicazione: (2026)
• Big data approach in the field of gastric and colorectal cancer research
  di: Ka Shing Cheung
  Pubblicazione: (2024)
• Relationship between Helicobacter pylori infection, osteoporosis, and fracture
  di: Jing Tong Tan, et al.
  Pubblicazione: (2024)
• Proton pump inhibitors associated with severe COVID‐19 among two‐dose but not three‐dose vaccine recipients
  di: Ka Shing Cheung, et al.
  Pubblicazione: (2024)